For Healthcare Professionals

Effectiveness of Treatment With Tofacitinib in Patients With Psoriatic Arthritis in Routine Clinical Practice


About the study

This is a Multinational Study of Tofacitinib in Patients Treated for Psoriatic Arthritis in order to evaluate the effectiveness of treatment with tofacitinib on disease activity, remission, and Quality of Life, in a real-world setting over a 12-month observation period

Who can take part

You may be eligible to participate in the study if you meet the following criteria:


Inclusion Criteria: Patients must meet all of the following inclusion criteria to be eligible for inclusion in the study:

  1. Patients aged ≥ 18 years
  2. Moderate to severe PsA disease activity diagnosed
  3. Patients for whom the physician's decision has been made to initiate treatment with tofacitinib, in usual clinical practice conditions and in compliance with the local label
  4. Patients are treatment naïve to tofacitinib on the date of providing informed consent
  5. Evidence of a personally signed and dated informed consent document indicating that the patient (or a legally acceptable representative) has been informed of all pertinent aspects of the study
  6. Patients on DMARDs must have not had a treatment change in the past 3 months


Exclusion Criteria: Patients meeting any of the following criteria will not be included in the study:

  1. Contraindications according to the Xeljanz® (tofacitinib) Prescribing Information
  2. Receipt of any investigational drug within 3 months before study inclusion
  3. Patient is pregnant or breastfeeding
  4. Recent herpes zoster infection (within past 6 months) or history of severe disseminated herpes zoster infection
  5. Active treatment for a malignancy
  6. Concomitant treatment with a biological disease-modifying antirheumatic drugs (bDMARD)
pin location

Study Locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to Apply

Contact the study center to learn if this study is a good match for you.

Study’s details


Psoriatic Arthritis

Age (in years)


Participants needed


Est. Completion Date

Jul 22, 2024

Treatment type

Observational [Patient Registry]


Pfizer identifier


Study number


Understanding Clinical Trials

Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?


Sign up to save your favorites, 
receive newsletters, resources, and alerts 
about clinical trials related to your conditions of interest.